235 related articles for article (PubMed ID: 31769216)
1. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
Li ZQ; Wang HY; Zeng QL; Yan JY; Hu YS; Li H; Yu ZJ
Cancer Med; 2020 Jan; 9(2):711-723. PubMed ID: 31769216
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.
Yang P; Li QJ; Feng Y; Zhang Y; Markowitz GJ; Ning S; Deng Y; Zhao J; Jiang S; Yuan Y; Wang HY; Cheng SQ; Xie D; Wang XF
Cancer Cell; 2012 Sep; 22(3):291-303. PubMed ID: 22975373
[TBL] [Abstract][Full Text] [Related]
3. N
Rao X; Lai L; Li X; Wang L; Li A; Yang Q
IUBMB Life; 2021 Feb; 73(2):408-417. PubMed ID: 33372396
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
5. CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma.
Gao Y; Fan X; Li N; Du C; Yang B; Qin W; Fu J; Markowitz GJ; Wang H; Ma J; Cheng S; Yang P
Pharmacol Res; 2020 Jul; 157():104800. PubMed ID: 32278046
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Zhang C; Liu P; Zhang C
J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
8. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis.
Jiang Z; Chen H; Su M; Wu L; Yu X; Liu Z
Bioengineered; 2021 Dec; 12(2):11277-11287. PubMed ID: 34874224
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma.
Song G; Zhu X; Xuan Z; Zhao L; Dong H; Chen J; Li Z; Song W; Jin C; Zhou M; Xie H; Zheng S; Song P
Theranostics; 2021; 11(5):2318-2333. PubMed ID: 33500727
[TBL] [Abstract][Full Text] [Related]
12. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
14. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated MicroRNA-181a induces carcinogenesis in hepatitis B virus-related hepatocellular carcinoma by targeting E2F5.
Zou C; Li Y; Cao Y; Zhang J; Jiang J; Sheng Y; Wang S; Huang A; Tang H
BMC Cancer; 2014 Feb; 14():97. PubMed ID: 24529171
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer.
Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW
Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403
[TBL] [Abstract][Full Text] [Related]
17. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
18. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
19. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1.
Chen Y; Zhao ZX; Huang F; Yuan XW; Deng L; Tang D
J Cell Physiol; 2019 Apr; 234(4):3555-3569. PubMed ID: 30565670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
